Atara Biotherapeutics Inc (0HIY.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
1280 Rancho Conejo Blvd
Thousand Oaks, CA 91320
United States of America (the)
Phone
650 278 8930
Website
Sector
Healthcare
Industry
Biotechnology
Employees
14
First IPO Date
January 29, 2018
| Name | Title | Pay | Year Born |
| Anhco Nguyen | President, Chief Executive Officer & Director | 1.07M | 1973 |
| Jim Sesic | Senior Vice President of Regulatory Affairs | 0 | N/A |
| Kevin G. Sarney | Interim Chief Financial Officer | 0 | 1965 |
| Yanina Grant-Huerta | Chief Accounting Officer & Principal Accounting Officer | 0 | 1978 |
| John Chao | Head of Legal | 0 | N/A |
| Alex Chapman | Vice President of Corporate Communications & Investor Relations | 0 | N/A |
Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.